Antiviral treatment for treatment-na ïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials
ConclusionsOur results are consonant with current clinical guidelines and other evidence reviews. For both HBeAg-positive and HBeAg-negative populations, TDF and TAF are the most effective agents for virologic suppression, and TAF is effective across all outcomes.
Source: Systematic Reviews - Category: International Medicine & Public Health Source Type: research
More News: Antiviral Therapy | Cancer & Oncology | Carcinoma | Cirrhosis | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | International Medicine & Public Health | Liver | Liver Cancer | Urology & Nephrology | Viread | Virology